Pharmaceutical Supply – Ophthalmic Antibiotic/Anti-Inflammatory Combination

This subcontract with the Defense Logistics Agency under the Department of Defense involves the supply and delivery of FDA-approved Ciprofloxacin Hydrochloride and Dexamethasone ophthalmic suspension. The contractor must ensure all products meet current Good Manufacturing Practice standards, including strict adherence to labeling and traceability requirements for use within the federal medical supply chain. The procurement falls under NAICS code 325412 and is managed through the Defense Logistics Agency. Key operational requirements focus on maintaining pharmaceutical quality and regulatory compliance to support medical readiness and distribution for the Department of Defense.